Provided by Tiger Fintech (Singapore) Pte. Ltd.

Bio-Techne

48.10
-1.8750-3.75%
Post-market: 48.100.00000.00%19:18 EDT
Volume:2.74M
Turnover:132.57M
Market Cap:7.60B
PE:49.09
High:50.00
Open:49.42
Low:47.70
Close:49.98
Loading ...

Benchmark Co. Reaffirms Their Buy Rating on Bio-Techne (TECH)

TIPRANKS
·
31 Oct 2024

Bio-Techne (TECH) Gets a Buy from Scotiabank

TIPRANKS
·
31 Oct 2024

Bio-Techne Is Maintained at Outperform by Baird

Dow Jones
·
31 Oct 2024

RBC Capital Reaffirms Their Hold Rating on Bio-Techne (TECH)

TIPRANKS
·
31 Oct 2024

Bio-Techne Corp (TECH) Q1 2025 Earnings Call Highlights: Navigating Growth and Challenges in a ...

GuruFocus.com
·
31 Oct 2024

Q1 2025 Bio-Techne Corp Earnings Call

Thomson Reuters StreetEvents
·
31 Oct 2024

Bio-Techne Tops Q1 Earnings & Revenue Estimates, Stock Up in Premarket

Zacks
·
31 Oct 2024

Bio-Techne Keeps Quarterly Dividend at $0.08 a Share, Payable Nov. 22 to Shareholders of Record as of Nov. 11

MT Newswires Live
·
30 Oct 2024

Bio-Techne Corp reports results for the quarter ended in September 30 - Earnings Summary

Reuters
·
30 Oct 2024

Stock Track | Bio-Techne Stock Soars 8.9% on Strong Q1 Results, Robust Diagnostics Demand

Stock Track
·
30 Oct 2024

Bio-Techne Shares up 8.5% After Q1 REV Beat

THOMSON REUTERS
·
30 Oct 2024

BUZZ-Bio-Techne rises after Q1 profit, revenue beat estimates

Reuters
·
30 Oct 2024

Bio-Techne beats quarterly profit estimates, driven by diagnostic unit growth; shares rise

Reuters
·
30 Oct 2024

Bio-Techne Fiscal Q1 Adjusted Earnings, Net Sales Rise

MT Newswires Live
·
30 Oct 2024

BRIEF-Bio-Techne Releases First Quarter Fiscal 2025 Results

Reuters
·
30 Oct 2024

Bio-Techne Corp (TECH) Q1 FY2025 Earnings: Revenue Surpasses Estimates at $289.5M, GAAP EPS Falls Short at $0.21

GuruFocus
·
30 Oct 2024

Stock Track | Bio-Techne Soars in Pre-Market as Q1 Earnings Top Estimates

Stock Track
·
30 Oct 2024

Bio-Techne Shares up 5.7% Premarket After Q1 REV Beat

THOMSON REUTERS
·
30 Oct 2024

Bio-Techne Q1 2025 Adj. EPS $0.42 Beats $0.38 Estimate, Sales $289.458M Beat $280.260M Estimate

Benzinga
·
30 Oct 2024

Bio-Techne Releases First Quarter Fiscal 2025 Results

THOMSON REUTERS
·
30 Oct 2024